Home › Funds › Atle Fund Management AB › GILD

Atle Fund Management AB position in GILD

GILEAD SCIENCES INC · Health Care

Atle Fund Management AB reported holding 40,461 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$6.0M, representing 1.62% of its reported portfolio and ranking #22 among its reported holdings. Atle Fund Management AB has disclosed GILD holdings in 9 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)40.46K sh
Reported value held$6.03M
Portfolio Weight1.62%
First reportedQ4 2023
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's GILD position evolved

Atle Fund Management AB first disclosed a stake in GILD in Q4 2023 at 98,974 shares (US$8.0M). The position peaked in Q1 2025 at 76,998 shares, worth US$8.6M. Across 9 filings, Atle Fund Management AB increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 40,461 shares valued at US$6.0M — a reduction of -5,681 shares quarter over quarter.. Notable position changes include a 47% trim in Q1 2024 (shares fell 6% over the following quarter), a 35% trim in Q4 2025 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 98.97K $8.02M New
Q1 2024 52.00K $3.81M Reduce
Q1 2025 77.00K $8.63M New
Q2 2025 73.17K $8.11M Reduce
Q3 2025 78.17K $921.16K Add
Q4 2025 50.80K $6.23M Reduce
Q1 2026 47.97K $7.16M Reduce
Q2 2026 46.14K $5.83M Reduce
Q3 2026 40.46K $6.03M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Atle Fund Management AB held GILD?

Atle Fund Management AB has disclosed GILD holdings in 9 of the last 12 reported quarters, going back to Q4 2023.

What is Atle Fund Management AB's current position in GILD?

As of Q3 2026, Atle Fund Management AB holds 40.46K shares of GILD (GILEAD SCIENCES INC), valued at $6.03M, representing 1.62% of its reported portfolio and ranking #22.

Has Atle Fund Management AB been buying or selling GILD?

In the latest 13F filing (Q3 2026), Atle Fund Management AB reduced its position in GILD. The position peaked in Q1 2025 at 77.00K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.